Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis

N Borisow, M Mori, S Kuwabara, M Scheel… - Frontiers in …, 2018 - frontiersin.org
Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …

MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder

GR Dos Passos, LM Oliveira, BK Da Costa… - Frontiers in …, 2018 - frontiersin.org
Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been found in
some cases diagnosed as seronegative neuromyelitis optica spectrum disorder (NMOSD) …

B cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-compartmentalized inflammation

L Michel, H Touil, NB Pikor, JL Gommerman… - Frontiers in …, 2015 - frontiersin.org
Clinical trial results of peripheral B cell depletion indicate abnormal proinflammatory B cell
properties, and particularly antibody-independent functions, contribute to relapsing MS …

Diagnosis and management of neuromyelitis optica spectrum disorders-An update

A Bruscolini, M Sacchetti, M La Cava, M Gharbiya… - Autoimmunity …, 2018 - Elsevier
Neuromyelitis optica (NMO) and Neuromyelitis optica spectrum disorders (NMOSD) are a
group of autoimmune conditions characterized by inflammatory involvement of the optic …

Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): a case-series and review

PM Elsbernd, WR Hoffman, JL Carter… - Multiple Sclerosis and …, 2021 - Elsevier
Background Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) is a CNS demyelinating disease distinct from neuromyelitis optica …

Oligoclonal bands: clinical utility and interpretation cues

S Carta, D Ferraro, S Ferrari, C Briani… - Critical reviews in …, 2022 - Taylor & Francis
Oligoclonal immunoglobulin G (IgG) bands (OCBs) are a useful diagnostic tool to detect a
central humoral response. In particular, cerebrospinal fluid (CSF)-restricted OCBs represent …

The immunology of neuromyelitis optica—current knowledge, clinical implications, controversies and future perspectives

M Jasiak-Zatonska, A Kalinowska-Lyszczarz… - International journal of …, 2016 - mdpi.com
Neuromyelitis optica (NMO) is an autoimmune, demyelinating disorder of the central
nervous system (CNS) with typical clinical manifestations of optic neuritis and acute …

Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review

P Schindler, O Aktas, M Ringelstein… - Expert Review of …, 2023 - Taylor & Francis
Introduction Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, often
debilitating neuroinflammatory disease, whose predominant clinical manifestations are …

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

FC Oertel, H Zimmermann, F Paul, AU Brandt - Epma Journal, 2018 - Springer
Neuromyelitis optica spectrum disorders (NMOSD) are mostly relapsing inflammatory
disorders of the central nervous system (CNS). Optic neuritis (ON) is the first NMOSD-related …

Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies

S Asseyer, G Cooper, F Paul - Frontiers in Neurology, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorders (NMOSDs) and myelin oligodendrocyte
glycoprotein-antibody-associated disease (MOGAD) are autoimmune inflammatory …